{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • Internal Series
  • On-Demand Activities
  • CE Planning Process
  • Calendar
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Clinical Updates in Lymphoma 2022


Clinical Updates in Lymphoma 2022 Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • View Exhibits
Add to Calendar Clinical Updates in Lymphoma 2022 10/1/2022 7:30:00 AM 10/1/2022 3:30:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/lymphomacme2022 Description: A chance for Lymphoma specialists to gather and discuss updates and advancements in lymphoma treatment and research, including highlights from the most recent scientific conferences. We will also discuss the future of lymphoma treatment and the current external environment. Cedars-Sinai Harvey Morse Conference Center false MM/DD/YYYY


Date & Location
Saturday, October 1, 2022, 7:30 AM - 3:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA

Target Audience
Specialties - Hematology, Imaging, Internal Medicine, Oncology, Pathology & Laboratory Medicine, Radiation Oncology, Radiology, Surgery

Overview
A chance for Lymphoma specialists to gather and discuss updates and advancements in lymphoma treatment and research, including highlights from the most recent scientific conferences. We will also discuss the future of lymphoma treatment and the current external environment.

Objectives
  1. Recognize the utility of molecular testing in the classification and treatment of lymphoma
  2. Identify current evidence based treatments for Hodgkin lymphoma, diffuse large B cell lymphoma, and peripheral T cell lymphoma
  3. Describe new treatments under development including bi-specific antibodies and CART therapies

Registration

Physicians: $100
Non-physicians: $75
Residents/Fellows: $50
Cedars-Sinai Resident/Fellows (In-person) - $0.00
Industry: $200


Health and Safety Protocol
Before registering for this event, please read our Health and Safety Protocol for current requirements pertaining to attending in-person events. 

 

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548. 



Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (5.00 hours), Non-Physician AMA Attendance (5.00 hours)


Keywords: LIVEAMAOncology



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Faculty Photos
Justin Darrah, MD
Cedars-Sinai
Course Director, Faculty
Advisor-Kite (Relationship has ended)|Advisor-Morphosys (Relationship has ended)
Faculty Photos
Akil Merchant, MD
Cedars-Sinai
Course Director, Faculty
Advisor-Novartis AG (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Morphosys (Relationship has ended)
Faculty Photos
Stephen Ansell, MD, PhD
Mayo Clinic
Faculty
PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Takeda Pharmaceuticals, Inc.|PrincipalNamedInvestigator-SeaGen|PrincipalNamedInvestigator-Regeneron|PrincipalNamedInvestigator-Pfizer|PrincipalNamedInvestigator-ADC Therapeutics
Faculty Photos
John Chute, MD
Cedars-Sinai
Faculty
Nothing to disclose
Faculty Photos
Wendy Cozen, D.O., M.P.H.
UCI
Faculty
Nothing to disclose
Celeste C Eno, PhD, FACMG
Cedars-Sinai Medical Center
Faculty
Nothing to disclose
Faculty Photos
Jane C Figueiredo, PhD
Cedars-Sinai Medical Center
Faculty
Nothing to disclose
Faculty Photos
Hannah Lee, MD
Cedars sinai
Faculty
Nothing to disclose
Faculty Photos
Ronald Paquette, MD
Cedars-Sinai
Faculty
Consultant-Servier|Consultant-Novartis AG
Faculty Photos
Sepehr Rokhsar, MD
Cedars-Sinai
Faculty
Speaker-Incyte Corporation
Faculty Photos
Joshua Sasine, MD, PhD
Cedars-Sinai
Faculty
Speaker-Kite Pharma (Relationship has ended)|Other: Video for internal Amgen use, not to be shown outside of Amgen. -Amgen (Relationship has ended)|Speaker-Bristol-Myers Squibb (Relationship has ended)

Saturday, October 1, 2022

Registration Check-in, Breakfast and Exhibits
7:30AM - 8:00AM
Welcome
8:00AM - 8:10AM
John Chute, MD
Hodgkin Lymphoma
8:10AM - 8:30AM
Sepehr Rokhsar, MD
Session 1: What's New In...

Diffuse Large B-Cell Lymphoma
8:30AM - 9:00AM
Justin Darrah, MD
T cell Lymphoma
9:00AM - 9:20AM
Akil Merchant, MD
Transplant for Lymphoma
9:20AM - 9:50AM
Ronald Paquette, MD
Coffee Break/Exhibits
9:50AM - 10:10AM
Keynote: Immune Checkpoint Inhibitors in Lymphoma
10:10AM - 11:10AM
Stephen Ansell, MD, PhD
Session 2: A paradigm shift in relapsed DLBCL

CAR T Cell Therapy
11:10AM - 11:40AM
Joshua Sasine, MD, PhD
Bi-specific Antibodies
11:40AM - 12:00PM
Justin Darrah, MD
Introduction to Case Discussion
12:00PM - 12:05PM
Hannah Lee, MD
Approaches for relapsed B cell lymphoma Auto v. CAR T v. bispecific v. Targeted v. Allo
12:05PM - 12:45PM
Joshua Sasine, MD, PhD
Justin Darrah, MD
Akil Merchant, MD
Lunch/Exhibits
12:45PM - 1:15PM
Session 3: Next generation diagnostics

Molecular Profiling
1:15PM - 1:35PM
Celeste C Eno, PhD, FACMG
Integrating the TME into Molecular Classification of Lymphoma
1:35PM - 2:00PM
Akil Merchant, MD
Coffee Break/Exhibits
2:00PM - 2:10PM
Session 4: Special Populations

Health Disparities in Lymphoma
2:10PM - 2:30PM
Wendy Cozen, D.O., M.P.H.
COVID vaccination in Hematologic Malignancy patients
2:30PM - 2:50PM
Jane C Figueiredo, PhD
Closing Remarks
2:50PM - 3:00PM
Justin Darrah, MD
Akil Merchant, MD

2022 Lymphoma Exhibits by Cedars-Sinai CME


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization.